ARTICLE | Distillery Therapeutics
Therapeutics: Lysine-specific demethylase 3A (KDM3A; JMJD1A)
February 11, 2016 8:00 AM UTC
Patient sample, cell culture and mouse studies suggest inhibiting KDM3A could help treat multiple myeloma (MM). In patients, MM cells had higher levels of KDM3A than normal plasma cells. In three huma...